Goldman Small Cap Research Issues Research Report on ML Capital Group, Inc.

BALTIMORE, June 17, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on ML Capital Group Inc. (OTCQB – MLCG). The Company produces, markets, and sells its products and services under the SuperStar brand name, including vapor pens, mobile applications, and books.

The electronic cigarette, or e-cig market, currently generates $3 billion in annual sales and industry experts forecast it could reach the $300 billion mark in the next ten years. ML Capital recently launched sales of its vapor pen and accessories for use with tobacco, e-liquid, and medicinal marijuana. The SuperStar Vapor Pen product line is an 8-piece vapor pen kit with a tobacco tip, e-liquid tip, and wax atomizer, and is available in 5 colors. The unique design and features of the SuperStar Vapor Pen set is that it can be used with both tobacco based products, as well as medical marijuana or cannabis in the form of liquid, wax, or dry ingredients.

With distribution and medical marijuana dispensary relationships in a handful of states, the Company has already begun to book wholesale and retail sales. Recent studies in the U.K. that indicate e-cigs and vapor pen usage serve as highly effective smoking cessation devices as well as an alternative to traditional tobacco-based cigarettes, helping to drive the market growth.

In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis.

"With sales jumping from $1 billion in 2012 to $3 billion in 2014, the e-cig market could emerge as one of the fastest growing consumer segments. Moreover future government guidelines and labeling could dramatically boost sales. Meanwhile, the recent $135M purchase of Blue eCigs by Lorillard, the 3rd largest tobacco seller in the U.S., demonstrates the huge market opportunity. Since ML Capital just recently launched sales of the core vapor pen, the Company represents an early stage opportunity and attractive valuation relative to its peers."

This press release contains excerpts of our most recently published sponsored research report on ML Capital Group Inc. Goldman Small Cap Research has been compensated a total of $4000 for a research subscription services by the Company. To view the sponsored research report, disclosures and disclaimers, or to download the report in its entirety, please visit www.goldmanresearch.com.

About Goldman Small Cap Research

Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters.  Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.  Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.

About ML Capital Group, Inc.

ML Capital Group, Inc.'s primary business consists of producing products and providing services that support the medical marijuana industry and enhances the lives of the patients that have turned to medical marijuana/cannabis to manage their various ailments. The Company currently produces and markets its products and services under the SuperStar brand name, including vapor pens, mobile applications, and books. The Company does not directly engage in the growing, manufacture, or distribution of medical marijuana, cannabis, or cannabis by-products, thus placing it as one of the safest types of companies in the medical marijuana industry.

For more information visit ML Capital Investors Relations: www.MLCapitalGroupInc.com.

Goldman Small Cap Research
Rob Goldman, Analyst
+1-410-609-7100
[email protected]

SOURCE Goldman Small Cap Research